Abstract
Although the efficacy of glycoprotein IIb/IIIa inhibition in non-ST-elevation acute coronary syndromes is greatest in patients who undergo percutaneous coronary intervention (PCI), it was hypothesized that high-risk patients managed without PCI also benefit. The TIMI risk score was calculated for 1,570 patients randomized to tirofiban plus heparin versus heparin in the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms trial. In high-risk patients (score > or =4) treated without PCI, tirofiban reduced the risk for death, myocardial infarction, and refractory ischemia at 30 days (28.8% vs 21.9%; odds ratio [OR] 0.69, p = 0.04). This benefit was similar in magnitude as that for patients who underwent PCI (32.4% vs 22.2%; OR 0.60, p = 0.06). No benefit was evident in low-risk patients.
References
May 23, 1998·The New England Journal of Medicine·UNKNOWN Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS)
Oct 6, 1999·Circulation·C HeeschenM L Simoons
Oct 12, 1999·Circulation·X Q ZhaoF L Sax
Nov 16, 1999·Circulation·E BoersmaM L Simoons
Nov 30, 1999·Lancet·C HeeschenH D White
Feb 23, 2000·Circulation·N S KleimanR A Harrington
Aug 11, 2000·JAMA : the Journal of the American Medical Association·E M AntmanE Braunwald
Jun 20, 2001·Circulation·L K NewbyE J Topol
Jun 27, 2001·Lancet·M L Simoons, UNKNOWN GUSTO IV-ACS Investigators
Jan 17, 2002·European Heart Journal·D A MorrowE Braunwald
Jul 20, 2002·The American Journal of Cardiology·Benjamin M SciricaEugene Braunwald
Sep 5, 2002·European Heart Journal·M RoffiE J Topol
Sep 25, 2002·Circulation·Christopher P Cannon
Jul 10, 2003·Journal of the American College of Cardiology·Eric D PetersonUNKNOWN National Registry of Myocardial Infarction (NRMI) 4 Investigators
Dec 9, 2003·American Heart Journal·Andrzej BudajUNKNOWN GRACE Investigators
Citations
Jan 13, 2006·Current Treatment Options in Cardiovascular Medicine·Benjamin M Scirica, David A Morrow
Dec 19, 2008·American Journal of Therapeutics·Rohit R Arora, Fasi Rai
Mar 31, 2007·BMJ : British Medical Journal·A Khavandi, P R Walker
Nov 13, 2008·Current Problems in Cardiology·Michael D Faulx, Gary S Francis
Feb 15, 2008·The American Journal of Emergency Medicine·William E BodenChadwick D Miller
Jan 31, 2006·American Heart Journal·David A AlterUNKNOWN SESAMI Study Group
Aug 19, 2007·Journal of the American College of Cardiology·Jeffrey L AndersonUNKNOWN Society for Academic Emergency Medicine
May 4, 2013·Journal of the American College of Cardiology·Jeffrey L AndersonClyde W Yancy
May 7, 2011·Journal of the American College of Cardiology·R Scott WrightUNKNOWN American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Mar 30, 2011·Circulation·Jeffrey L AndersonUNKNOWN ACCF/AHA TASK FORCE MEMBERS
Aug 8, 2007·Circulation·Jeffrey L AndersonUNKNOWN Society for Academic Emergency Medicine
May 1, 2013·Circulation·Jeffrey L AndersonUNKNOWN American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Jan 30, 2008·Clinical Cardiology·Hector M Medina, Deepak L Bhatt